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ABSTRACT
BACKGROUNDAND PURPOSE: Limited information is available regarding differences in neuroimaging use for acute stroke work-up. Our
objective was to assess whether race, sex, or age differences exist in neuroimaging use and whether these differences depend on the care
center type in a population-based study.
MATERIALS AND METHODS: Patients with stroke (ischemic and hemorrhagic) and transient ischemic attack were identified in a metro-
politan, biracial population using the Greater Cincinnati/Northern Kentucky Stroke Study in 2005 and 2010. Multivariable regression was
used to determine the odds of advanced imaging use (CT angiography/MR imaging/MR angiography) for race, sex, and age.
RESULTS: In 2005 and 2010, there were 3471 and 3431 stroke/TIA events, respectively. If one adjusted for covariates, the odds of advanced
imagingwere higher for younger (55 years or younger) comparedwith older patients, blacks comparedwithwhites, and patients presenting
to an academic center and those seen by a stroke team or neurologist. The observed association between race and advanced imaging
depended on age; in the older age group, blacks had higher odds of advanced imaging compared with whites (odds ratio, 1.34; 95% CI,
1.12–1.61; P .01), and in the younger group, the association between race and advanced imaging was not statistically significant. Age by race
interaction persisted in the academic center subgroup (P  .01), but not in the nonacademic center subgroup (P  .58). No significant
association was found between sex and advanced imaging.
CONCLUSIONS: Within a large, biracial stroke/TIA population, there is variation in the use of advanced neuroimaging by age and race,
depending on the care center type.
ABBREVIATION: GCNKSS Greater Cincinnati/Northern Kentucky Stroke Study
Stroke is the fifth leading cause of death and a leading cause ofdisability in the United States.1 According to national mortal-
ity statistics from the Centers from Disease Control and Preven-
tion, racial disparities in mortality were largest for stroke, among
the leading causes of death.2 The National Health and Nutrition
Survey Epidemiologic Follow-Up Study3 estimated thatmortality
due to cerebrovascular disease accounted for 28% of the differ-
ence in total mortality rates between blacks and whites. During
2010–2013, stroke mortality among those aged 45 and older var-
ied by age and race. There was amarkedly higher stroke death rate
in non-Hispanic black individuals than in any of the other race-
ethnicity groups, and a greater portion of their stroke deaths oc-
curred at younger ages (45–64 years).4 Studying trends in stroke
incidence and case fatality is critical for the planning, implemen-
tation, and evaluation of the public health effort to decrease the
burden of stroke in the United States.
Previous studies have shown compelling sex, racial, and socio-
economic disparities in the treatment and outcomes among pa-
tients with acute stroke.5-7 Generally, racial minorities and
women with acute stroke have lower quality hospital care,5,8-13
including the use of imaging. These disparities can contribute to
inequality in stroke outcomes and are a top research priority of
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the National Institute of Neurologic Disorders and Stroke. The
management of stroke begins with the appropriate diagnostic
work-up. Imaging is an important component in both evaluation
and decision-making in patients presenting with suspected acute
stroke. In particular, early vascular imaging, such as CTA/MRA, is
now critical for clinical decision-making in patients potentially
eligible for endovascular therapy, and urgent brain MR imaging
and vascular imaging are recommended in suspected transient
ischemic attack.14 Although numerous publications have high-
lighted the disparities in stroke care, very limited data describe
demographic differences in neuroimaging use in a population.
These observations motivated us to examine data from a large
population-based cohort for evidence of systematically different
imagingwork-up in patientswith stroke based on race, sex, or age.
If the sources and causes of disparities in stroke care are recog-
nized, these can then inform the setup of programs and initiatives
to improve stroke care. This information will also be critical as we
transition to value-based health care.
The Greater Cincinnati/Northern Kentucky Stroke Study
(GCNKSS) is designed to investigate stroke incidence rates and
case fatality in a biracial population (blacks and whites) of a
5-county region that includes the city of Cincinnati. Our objective
was to assess whether race, sex, or age differences exist in neuro-
imaging use in routine acute stroke practice within this large,
metropolitan, population-based cohort and whether these differ-
ences depend on care center type.
MATERIALS AND METHODS
Study Design/Study Population
This was a retrospective, population-based study of all adults (20
years of age and older) with acute stroke among residents of a
5-county region of Southwest Ohio and Northern Kentucky dur-
ing 2005 and 2010. Patients with acute stroke (ischemic and hem-
orrhagic) and TIA were identified in a population of 1.3 million
served by 15 different inpatient hospitals in the Greater Cincinnati/
NorthernKentuckyarea.TheGCNKSS involvedascertainmentof all
stroke events that occurred in the population in 2005 and 2010.
Methodology and Study Population of the GCNKSS
The detailed methodology of GCNKSS has been published be-
fore.15 The study population is defined as all residents of the
Greater Cincinnati/Northern Kentucky region, which includes 2
Southern Ohio counties and 3 contiguous Northern Kentucky
counties that abut the Ohio River. The study population of the
Greater Cincinnati/Northern Kentucky region consists of 3%
Hispanic and other minorities; all self-identified black or white
subjects were included in our analysis. There were 2 methods
of screening: retrospective review of discharge diagnoses and pro-
spective monitoring of emergency department visits and admis-
sion lists. To qualify as an incidence case, a person must have met
the criteria for 1 of the 5 stroke/TIA subcategories, lived at a zip
code within the 5-county region at the time of stroke onset, and
had the onset of stroke in 2005 (between January 1, 2005, and
December 31, 2005) or 2010 (between January 1, 2010, and De-
cember 31, 2010). Strokes were classified as first-ever or recurrent
on the basis of evidence of prior clinical stroke in the medical
record. The date and type of each prior stroke or TIA were re-
corded, and any neurologic deficit present before the current
stroke or TIA was documented. We have current institutional
review board approval at all the regional hospitals.
Clinical and Imaging Data Abstraction
Screening. Screening techniques were identical in both the 2005
and 2010 study periods. Study nurses prospectively screened the
medical records of all inpatients with primary or secondary
stroke–related International Classification of Diseases, 9th Revision
discharge diagnoses from the 15 acute care hospitals in the study
region. The International Classification of Diseases, 9th Revision-
Clinical Modification codes (both primary and secondary dis-
charge diagnoses) for retrieving medical records included 430–
436. In addition, strokes not found by inpatient screening were
ascertained by monitoring all stroke-related visits to hospital
emergency departments (with the exception of the Cincinnati
Children’s Hospital Medical Center). Patient charts and imaging
records abstracted by research nurseswere reviewed by study phy-
sicians. Study physicians reviewed every abstract to verify whether
a stroke or TIA had occurred and then assigned a stroke category
and mechanism to each event on the basis of all available infor-
mation, using definitions described previously.16
Stroke Case Adjudication. Study nurses and physicians were
trained extensively before case review, and detailed instructions
guided reviewers on screening, abstraction, and case review. Spe-
cifically, study physicians reviewed all data fromeach case, includ-
ing clinical scenarios, presenting symptoms, and imaging (CT
and/or MR imaging reports, and images if physician-requested).
In addition, senior investigators reviewed a select sample of cases
from all physician reviewers to ensure accuracy of case ascertain-
ment, and any discrepancies or questionable cases were resolved
by senior investigators.
We included all acute ischemic or hemorrhagic stroke or TIA
cases ascertained in the hospital setting, including all emergency
departments and inpatient services (direct admissions and in-
hospital events). The cases included in this analysis were restricted
to hospitalized patients because the collection of outpatient im-
aging performed in a nursing home or physician’s office setting
was not pursued in the study. Socioeconomic status was deter-
mined by the percentage below the poverty level within a respon-
dent’s US 2000 Census Tract of residence and dichotomized at
high poverty20%.17
Data Analysis
The proportion of noncontrast CT, CT angiograms,MR imaging,
MR angiograms, and carotid sonograms within 2 days of stroke/
TIA symptom onset was computed by sex, age (55 or younger or
older than 55 years), and race (white or black) demographic
groups.We specifically used the 2-day limit to capture all imaging
performed for both acute stroke and TIA work-up. In our previ-
ous work,18 we found a trend toward an increased incidence of
ischemic stroke in the young (20–54 years of age) for both black
and white patients. We used this same age limit (55 years) to
dichotomize the current study group into young versus old.
We used multivariable logistic regression to determine the
odds of advanced imaging use for the demographic variables of
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interest (age, sex, and race), adjusting for additional covariates.
We defined advanced imaging as additional CT or MR imaging,
including CTA head and/or neck, MR imaging brain, and MRA
head and/or neck. Covariates included NIHSS score; an indicator
for high poverty (percentage below poverty level 20%); emer-
gency department presentation; insurance; type of case (hemor-
rhagic, ischemic, or TIA); seen by the stroke team or neurologist;
type of care center (academic or nonacademic); and study year
(2005 or 2010). We defined “academic center” as one with a neu-
rology residency program where neurology is the primary admit-
ting service for patients with stroke. Interaction terms for study
year by age, sex, and race and age by race, age by sex, and race by
sex were evaluated in the model with a P .05 considered statis-
tically significant. Statistically significant interactions were de-
scribed by stratification by the effectmodifier. Last, we also stratified
cases on the basis of type of care center to evaluate whether any ob-
served associations were consistent across the type of care center,
with further stratification by any significant effect modifiers.
RESULTS
In 2005, there were 3471 stroke/TIA events with imaging data
available in 3226 patients; and in 2010, there were 3431 stroke/
TIA events with imaging data available in 3213 patients. Because
demographic differences in imaging use did not differ signifi-
cantly between the calendar years 2005 and 2010, data for the 2
years were combined. The median age for the combined group
was 72 years, 20% were black, 57% were women, and the median
NIHSS score was 3 (Table 1). A higher proportion of men under-
went MR imaging (55% versus 51%, P  .01) and MRA (36%
versus 31%, P .01) compared with women, with no sex differ-
ences in the use of NCCT, carotid sonography, or CTA. A higher
proportion of blacks underwent NCCT (96% versus 92%), MR
imaging (59% versus 51%), and MRA (41% versus 31%) com-
pared with whites (P  .01), with no racial difference in CTA.
Advanced imaging use (MR imaging, CTA, MRA) was higher in
younger (55 years or younger) compared with older patients
(older than 55 years) (68% versus 52%, P  .01), whereas older
patients underwent a higher proportion of carotid sonography
(43% versus 36%, P .01) (Table 2).
Multivariable Analysis
After we adjusted for covariates, younger age (55 years or
younger) was associated with higher odds of advanced imaging
compared with older age (older than 55) (adjusted odds ratio,
1.90; 95%CI, 1.63–2.22; P .01). Compared with white patients,
black patients had significantly higher odds of additional ad-
vanced imaging (OR, 1.27; 95%CI, 1.08–1.49; P .01). The odds
of advanced imaging were also higher if patients presented to an
academic center or were seen by a stroke team or neurologist. No
statistically significant association was found between sex and ad-
vanced imaging (Table 3). A higher NIHSS score was associated
with decreased advanced imaging (OR, 0.93; 95% CI, 0.92–0.94;
P .01).
We found a significant age-by-race interaction so that the as-
sociation between race and advanced imaging was dependent on
age. After we adjusted for covariates, in the older age group, black
race was associated with higher odds of advanced imaging com-
pared with white race (OR, 1.34; 95% CI, 1.12–1.61; P  .01).
However, in the younger age group, the association between race
and advanced imaging was not statistically significant (Table 3).
No statistically significant interactions were found between study
year and age, sex, and race, between age and sex, and between age
and race.
In subgroup analyses by type of center, the age-by-race inter-
action persisted in the academic center subgroup (P  .01), but
not in the nonacademic center subgroup (P  .58). In the aca-
demic center, in the older age group, black race was associated
with higher odds of advanced imaging compared with white race
Table 1: Demographics and clinical characteristics overall and by
study yeara
All
(N = 6902)
2005
(n = 3471)
2010
(n = 3431)
Age (median) (IQR) 72 (59–81) 72 (59–81) 71 (58–82)
Race
Black 1355 (20%) 659 (19%) 696 (20%)
White 5505 (80%) 2791 (80%) 2714 (79%)
Other 42 (1%) 21 (1%) 21 (1%)
Sex, female 3906 (57%) 1968 (57%) 1938 (56%)
Percentage below
poverty20%
754 (11%) 399 (12%) 355 (10%)
Care center
Academic 1026 (15%) 440 (13%) 586 (17%)
Nonacademic 5876 (85%) 3031 (87%) 2845 (83%)
ED presentation 6023 (87%) 2955 (85%) 3068 (89%)
Insurance
Any 6319 (94%) 3159 (95%) 3160 (93%)
Self-pay 415 (6%) 172 (5%) 243 (7%)
NIHSS (median) (IQR) 3 (1–7) 3 (1–7) 2 (1–6)
Case type
Hemorrhagic 821 (12%) 427 (12%) 394 (11%)
Ischemic 4412 (64%) 2147 (62%) 2265 (66%)
TIA 1669 (24%) 897 (26%) 772 (22%)
Seen by stroke team
or neurologist
4287 (62%) 2006 (58%) 2281 (66%)
Note:—IQR indicates interquartile range; ED, emergency department.
a Data are No. (%) unless otherwise indicated.
Table 2: Unadjusted neuroimaging use for stroke/TIA work-up by sex, age, and race for combined study periods of 2005 and 2010a
Sex Age (yr) Race
Men
(n = 2996)
Women
(n = 3906)
P
Value
55 or Younger
(n = 1343)
Older Than 55
(n = 5559)
P
Value
Black
(n = 1355)
White
(n = 5505)
P
Value
NCCT 2778 (93%) 3649 (93%) .26 1265 (94%) 5162 (93%) .08 1296 (96%) 5091 (92%) .01
MRI 1633 (55%) 1983 (51%) .01 851 (63%) 2765 (50%) .01 801 (59%) 2788 (51%) .01
CTA 163 (5%) 184 (5%) .17 130 (10%) 217 (4%) .01 81 (6%) 263 (5%) .07
MRA 1075 (36%) 1206 (31%) .01 569 (42%) 1712 (31%) .01 561 (41%) 1703 (31%) .01
Any advanced imaging 1718 (57%) 2104 (54%) .01 916 (68%) 2906 (52%) .01 847 (63%) 2948 (54%) .01
Carotid sonography 1246 (42%) 1614 (41%) .82 482 (36%) 2378 (43%) .01 417 (31%) 2425 (44%) .01
a Data are No. (%) unless otherwise indicated.
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(OR, 1.80; 1.12–1.61; P  .01). However, in the younger age
group, the association between black race and advanced imaging
was in the opposite direction and not statistically significant
(Table 4). In the nonacademic center, black race was associated
with higher odds of advanced imaging in both age groups (un-
stratified OR, 1.28; 95% CI, 1.07–1.53; P .01).
DISCUSSION
The principal finding of our study is that younger patients (55
year or younger) and black patients were more likely to undergo
advanced imaging for acute stroke/TIA work-up. Although men
underwent a significantly higher proportion of MR imaging/
MRA inunadjusted analyses, this associationwas not present after
adjusting for covariates. Additionally, we did not find a significant
difference in the use of advanced imaging by insurance or socio-
economic status.
Prior studies have shown demographic differences in the use
of neuroimaging for acute stroke.15,19 Large variation was re-
ported among English public hospitals, where younger patients,
men, and patients of higher socioeconomic status were more
likely to undergo brain imaging (NCCT or MR imaging).11 A
study using the Canadian Stroke Registry found that very elderly
patients were less likely to undergo carotid imaging compared
with younger patients with acute ischemic stroke, though there
was no association between age and the quality of stroke care.17 In
our analysis, a higher proportion of the older patients underwent
carotid sonography rather than CTA or MRA, compared with
younger patients. A possible explanation is that older patients are
less suitable candidates for carotid endarterectomy or carotid ar-
tery stent placement due to other comorbidities, including de-
mentia; therefore, advanced vascular imaging is less likely to be
performed. Additionally, younger patients may have more stroke
mimics, leading to increased advanced imaging.
The strength of our study is that it is the largest population-
based dataset capturing detailed clinical information regarding
stroke care in the United States, and it is one of the few studies
with a substantial number of black patients. In addition, our da-
taset represents a large,metropolitan population representative of
the United States population with respect to median age, median
income, black race, female sex, and rate below the poverty
level.16,20
There is a distinct advantage in using a population-based
source of information regarding imaging use patterns. Popula-
Table 3: Multivariable model for advanced imaging (CTA/MRI/MRA) for stroke/TIA work-up in the overall group stratified by age
groups
Overall 55 yr or Younger Older Than 55 yr
OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Age 55 yr or younger 1.90 (1.63–2.22) .01 – – – –
Race, black (reference white)a 1.27 (1.08–1.49) .01 1.02 (0.73–1.41) .92 1.34 (1.12–1.61) .01
Sex, male 1.06 (0.95–1.18) .32 1.06 (0.81–1.39) .69 1.06 (0.94–1.20) .31
Academic 1.43 (1.20–1.71) .01 1.21 (0.85–1.72) .29 1.51 (1.22–1.85) .01
High poverty 0.85 (0.69–1.03) .10 0.71 (0.49–1.04) .08 0.91 (0.73–1.15) .44
ED presentation 1.95 (1.65–2.29) .01 2.74 (1.81–4.14) .01 1.84 (1.54–2.19) .01
Insurance (any, reference self-pay) 0.91 (0.70–1.18) .47 0.90 (0.63–1.28) .56 0.94 (0.64–1.39) .76
NIHSS score 0.93 (0.92–0.94) .01 0.93 (0.92–0.95) .01 0.93 (0.92–0.94) .01
Event type (reference TIA)
ICH/SAH 1.22 (0.99–1.50) .07 1.98 (1.26–3.12) .01 1.04 (0.82–1.33) .72
Infarct 2.51 (2.19–2.88) .01 2.46 (1.78–3.41) .01 2.50 (2.16–2.91) .01
Seen by stroke team or neurologist 2.33 (2.07–2.63) .01 3.25 (2.38–4.43) .01 2.22 (1.95–2.53) .01
Study year 2010 (reference 2005) 1.66 (1.48–1.85) .01 1.77 (1.35–2.33) .01 1.64 (1.46–1.85) .01
Note:—ED indicates emergency department; ICH, intracranial hemorrhage.
a Race by age group interaction (P .04).
Table 4: Multivariable model for advanced imaging (CTA/MRI/MRA) for stroke/TIA work-up stratified by care center type and age
groups
Academic Center (n = 1026)a Nonacademic Centers (n = 5876)b
55 yr or Younger Older Than 55 yr 55 yr or Younger Older Than 55 yr
OR (95% CI)
P
Value OR (95% CI)
P
Value OR (95% CI)
P
Value OR (95% CI)
P
Value
Race, black (reference white) 0.56 (0.30–1.04) .07 1.80 (1.19–2.72) .01 1.25 (0.82–1.89) .29 1.27 (1.04–1.55) .02
Sex, male 1.00 (0.58–1.72) .99 1.25 (0.88–1.78) .22 1.12 (0.82–1.54) .48 1.05 (0.92–1.20) .46
High poverty 0.98 (0.51–1.85) .94 0.74 (0.47–1.17) .20 0.64 (0.40–1.03) .07 0.98 (0.75–1.28) .89
ED presentation 2.09 (0.89–4.91) .09 1.79 (1.03–3.12) .04 3.19 (1.94–5.24) .01 1.83 (1.52–2.20) .01
Insurance (any, reference self-pay) 0.77 (0.45–1.33) .35 0.84 (0.45–1.56) .58 0.92 (0.57–1.47) .73 0.99 (0.61–1.60) .95
NIHSS 0.94 (0.92–0.97) .01 0.94 (0.92–0.95) .01 0.91 (0.89–0.94) .01 0.93 (0.92–0.94) .01
Event type (reference TIA)
ICH/SAH 0.99 (0.34–2.85) .98 1.54 (0.80–2.96) .20 2.46 (1.40–4.34) .01 0.87 (0.65–1.17) .37
Infarct 2.12 (0.93–4.88) .08 1.85 (1.10–3.11) .02 2.44 (1.68–3.55) .01 2.58 (2.20–3.01) .01
Seen by stroke team or neurologist 2.39 (1.02–5.56) .04 3.02 (1.75–5.20) .01 3.80 (2.68–5.38) .01 2.21 (1.93–2.53) .01
Study year 2010 (reference 2005) 3.84 (2.23–6.62) .01 1.88 (1.31–2.68) .01 1.38 (1.00–1.90) .05 1.61 (1.42–1.83) .01
Note:—ED indicates emergency department; ICH, intracranial hemorrhage.
a In the academic care center subgroup: race by age group interaction (P .01).
b In the nonacademic care center subgroup: race by age group interaction (P .58).
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tion-based epidemiologic studies of stroke fall into 2 broad
classes: 1) surveillance studies, and 2) cohort studies; both are
needed to fully understand stroke incidence and disparities. Just
as cohort studies are critical to the understanding of the causes of
stroke, surveillance studies are critical to determining the distri-
bution of stroke; and both contribute to knowledge regarding
important public health trends in stroke. Similarly, administra-
tive data provide complementary data to population-based stud-
ies by providing access to large numbers of cases with lower costs.
However, administrative data lack the ability to answer clinical
questions, have incomplete ascertainment, and have limited ac-
cess to special populations. Registries, such as Get With the
Guidelines,21 provide more clinical information than purely ad-
ministrative data, though they are still limited compared with
population-based studies. Providing data in these registries by
hospitals demonstrates a willingness to participate in stroke qual-
ity-improvement projects, indicating a bias at the hospital level.
Most surprising, in contrast to concerns that blacks may re-
ceive less diagnostic work-up, we found that overall, blacks re-
ceived more advanced imaging than whites. A possible explana-
tion is that in our population, the only large, academic hospital in
the region admits a greater proportion of black patients. Further-
more, the racial difference depended on age and type of care cen-
ter, with potential differential access to stroke expertise. A retro-
spective analysis of US Department of Veterans Affairs Hospital
systems also suggested sites of care as a factor for disparities by
demonstrating that white patients at nonminority-serving hospi-
tals had a significantly higher probability of undergoing carotid
imaging than either black or white patients at minority-serving
hospitals.22 In addition, there may be clinical differences between
strokes in blacks and whites in our study, including variations in
vascular risk factors prompting advanced imaging work-up. We
also found that the odds of advanced imaging were higher if pa-
tients were seen by a stroke team or neurologist, suggesting that
physician factors can have a substantial effect on imaging use.
This finding has also been demonstrated in a large retrospective
cohort study examining factors affecting the use of outpatient
imaging, where specialists ordered 43.6% compared with 27.5%
ordered by primary care physicians.23
Disparity in health care is being increasingly recognized;
hence, an overarching goal of theHealthy People 2020 initiative is
“to achieve health equity, eliminate disparities, and improve the
health of all groups” in the United States.24 A recent study dem-
onstrated a significant gap between metropolitan and nonmetro-
politan area hospitals, especially with the rate of recombinant tis-
sue plasminogen activator administration and provision of stroke
education.25 Even more alarming is that this rural-urban geo-
graphic disparity gap in rtPA use is increasing.26 Several deficien-
cies contribute to the disparity in stroke care, including wide-
spread geographic variation and access issues. Furthermore, the
prehospital recognition of stroke is lower among minority pa-
tients compared with non-Hispanic whites and, similarly, lower
for female compared with male patients,27 highlighting the im-
portance of identifying all links in the chain of stroke care. Lack of
awareness, socioeconomic factors, cultural impediments, and po-
tential existence of bias are additional barriers in the delivery of
care.5
Change in the incidence and outcome of a disease and the
reduction of clearly identified disparities in these rates and out-
comes are the ultimate test of how well science has translated new
discoveries into benefits for the population. Because stroke is the
most frequent neurologic cause of death and a leading cause of
major disability, it should be a primary focus for neurologic sur-
veillance studies. Understanding use of standard of care (NCCT)
versus advanced imaging (MR imaging/CTA/MRA) is important
because additional diagnostic imaging, including vascular imag-
ing, can help guide treatment decisions and elucidate etiology and
recurrence risk in patients with stroke and TIA. The understand-
ing of the differential use of imaging in various centers, different
age groups, and the “at-risk” population is crucial to designing
future interventions to reduce stroke risk and quantify the need
for standardization of care.
There are a few important limitations to our study, including
the retrospective nature. There is a potential for bias of incom-
plete case ascertainment, though our method of identification of
hospitalized strokes is well-defined and remained consistent
across the study periods. Despite the surveillance methods in
place, it is possible that some cases of stroke and TIAweremissed.
Although imaging may have an effect on the detection and diag-
nosis of stroke, the case definition for stroke used in this analysis
for both study periods was based strictly on clinical criteria, sup-
ported by imaging findings. Another limitation is that the neuro-
imaging use rates are from older 2005 and 2010 cohorts. We plan
to study the imaging use in the 2015 GCNKSS cohort (data col-
lection for the same is underway). Our study also does not have
the ability to track how the use of imaging affected clinical deci-
sion-making and/or outcomes in the stroke population; however,
this area is an important focus for future research.
CONCLUSIONS
Age- and race-related differences exist in the use of neuroimaging
for patients with stroke/TIA, which depends on care center type.
Clearly, much work is still needed to understand these disparities.
Deconstructing the differences in utilization data must continue
because this can provide an important basis for lines of inquiry
into socioeconomic and access-to-stroke-care issues. These data
are critical for focusing and monitoring the success of the public
health effort in decreasing disability and mortality due to stroke.
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